Chairman talks about "five important" work in the second half of the year"
Release time:
2020-08-17
Work Direction Unchanged, Annual Target Unchanged
Chairman Talks about "Five Requirements" for Work in the Second Half of the Year
News 7# July 18 , Chairman Jiang Xiaomeng of the Group Company made a concluding speech at the Company's 2020 Work Analysis Meeting in the First Half of the Year, putting forward five work requirements for the work in the second half of the year.
Jiang Xiaomeng pointed out that since the beginning of this year, great changes have taken place in the world political, economic structure and even the climate environment. The global economy has fallen into a downturn, which has added a lot of uncertainty to the future development of enterprises. At the same time, the continuous strengthening of the country's counter-cyclical adjustment and the introduction of various policies to restore the economy have also brought new development opportunities for enterprises. In this case, the focus of the work of the peak cement sector is to strive to achieve full-load operation of equipment to increase output, increase investment in equipment and technological transformation to improve performance, improve technology, and use modern technology to improve labor productivity; the pharmaceutical sector should increase The research and development of new products, speed up the implementation of new projects, and lay a good foundation for the implementation of various national medical system reform measures in the future. To this end, all enterprises of the company should earnestly do a good job in five aspects:should do a good job in promoting key projects. Guizhou peak will be the company's new profit growth point, to complete the construction as soon as possible, put into production as soon as possible; The internationalization project of the pharmaceutical sector and the technological transformation of North Carolina, New North Carolina and Zhongwang should be carried out as soon as possible, and efforts should be made to speed up the application progress for new drug products that are mainly developed.
to accelerate industrial transformation and upgrading, and constantly achieve self-improvement. It is necessary to understand new things, new technologies, and new methods in a timely manner, such as the intelligence of cement production, the integration of numerical control, the digital control of pharmaceutical companies, and the car-free transportation of bonded logistics, etc., and effectively apply them to practical work to improve The core competitiveness of the enterprise itself.
We should fully grasp the development opportunities and realize the effective integration of resources. It is necessary to do a good job in the organic integration of North Carolina and Jianfeng Pharmaceutical, realize the effective allocation of equipment and resources, realize the organic complementarity of scientific researchers, and form a synergistic effect of API R & D center, preparation research and production center and multi-functional API intermediate production base in the whole industry chain; we should continue to look for development opportunities in the cement industry, further consolidate and strengthen the market position of Jianfeng Cement, continuously expand the scale of enterprises and improve profitability; international trading companies should also further accelerate the upgrading and transformation on the basis of the current integration of warehousing and logistics business, so as to strive for better development opportunities.
We should constantly improve the system construction to ensure the stable development of enterprises. As the scale of peak enterprises becomes larger and larger, the management radius becomes longer and longer, and the need to strengthen the construction of the system is becoming more and more urgent. In the future work, it is necessary to continuously establish and improve a set of supervision, assessment, reward and punishment mechanisms that are truly suitable for the actual situation of the enterprise, to focus on strengthening the supervision of procurement and bidding, to do a good job in safety and environmental protection management, and to continuously improve the talent training and introduction Mechanism, only to establish a complete management system that can truly restrict all employees and even senior executives, in order to lay a solid foundation for the stable development of the enterprise in the future.
We must continuously strengthen party building. Organizational construction is an important foundation for party building. All enterprises must use party building to lead industrial construction, implement the party's organizational line in the new era, and lead the sound development of the entire enterprise through strong party organization construction; all party members and cadres must play a good role Model and take the lead to create a clean and upright cultural atmosphere and internal environment for the development of the enterprise.
Jiang Xiaomeng stressed that enterprises that are self-contained and feel good about themselves will eventually be eliminated by the market, and peak people must not sit on the sidelines and meet the status quo. Only by carefully judging the situation, strengthening self-cultivation, taking advantage of the situation and taking advantage of the situation, can we go far and steadily. Although in the first half of the year due to the epidemic and other factors, the company's efficiency has declined year-on-year, but the company's work direction will not change, the business objectives set at the beginning of the year will not change. All enterprises should give full play to the strength of all employees, make unremitting efforts in the second half of the year, and strive to successfully complete the work throughout the year. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31